To include your compound in the COVID-19 Resource Center, submit it here.

SkyePharma, GeneMedix formulation deal

SkyePharma (LSE:SKP; SKYE) and GeneMedix (LSE:GMX) partnered to develop an

Read the full 105 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE